1. IMPACT OF MAJOR GENOMIC ALTERATIONS ON OUTCOME OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS RECEIVING VENETOCLAX PLUS RITUXIMAB IN THE PHASE 3 MURANO STUDY. (12th June 2019) Authors: Wu, J.; Bolen, C.; Seymour, J.F.; Hillmen, P.; Eichhorst, B.; Eldering, E.; Kipps, T.J.; Langerak, A.W.; Mellink, C.; van der Kevie‐Kersemaekers, A.F.; Owen, C.; Chyla, B.; Punnoose, E.A.; Wang, J.; Boyer, M.; Humphrey, K.; Jiang, Y.; Kater, A.P. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P561: VIALE-T: A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF VENETOCLAX IN COMBINATION WITH AZACITIDINE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA. (23rd June 2022) Authors: Craddock, C.; Platzbecker, U.; Heuser, M.; Pullarkat, V.; Chaudhury, S.; Wu, D.; Addo, S.; Chyla, B.; Jiang, Q.; Lee, P.; Wolff, J. E. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 460 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S143: TRANSCRIPTOMIC CHARACTERIZATION OF MRD RESPONSE AND NON-RESPONSE IN PATIENTS TREATED WITH FIXED-DURATION VENETOCLAX-OBINUTUZUMAB. (23rd June 2022) Authors: Al-Sawaf, O.; Jin, H. Y.; Zhang, C.; Choi, Y.; Balasubramanian, S.; Robrecht, S.; Kotak, A.; Chang, N.; Fink, A.-M.; Tausch, E.; Schneider, C.; Ritgen, M.; Kreuzer, K.-A.; Chyla, B.; Paulson, J.; Eichhorst, B.; Stilgenbauer, S.; Jiang, Y.; Hallek, M.; Fischer, K. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. S146: VENETOCLAX IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITH 17P DELETION: 6-YEAR FOLLOW-UP AND GENOMIC ANALYSES IN A PIVOTAL PHASE 2 TRIAL. (23rd June 2022) Authors: Stilgenbauer, S.; Tausch, E.; Roberts, A. W.; Davids, M. S.; Eichhorst, B.; Hallek, M.; Hillmen, P.; Schneider, C.; Böttcher, S.; Popovic, R.; Ghanim, M. T.; Moran, M.; Sinai, W. J.; Wang, X.; Mukherjee, N.; Chyla, B.; Wierda, W. G.; Seymour, J. F. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. S148: VENETOCLAX-OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 5-YEAR RESULTS OF THE RANDOMIZED CLL14 STUDY. (23rd June 2022) Authors: Al-Sawaf, O.; Zhang, C.; Robrecht, S.; Kotak, A.; Chang, N.; Fink, A.-M.; Tausch, E.; Schneider, C.; Ritgen, M.; Kreuzer, K.-A.; Chyla, B.; Eichhorst, B.; Jiang, Y.; Stilgenbauer, S.; Hallek, M.; Fischer, K. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗